Dutasteride for Hair Loss: When It Enters the Conversation
Not first-line for everyone — when clinicians may discuss it, what ‘stronger’ gets wrong, and how it fits a long-term plan with supervision.
When the name comes up: diagnosis-led discussion, access, and honest timelines — not forum dosing.
